UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prasugrel: A Critical Comparison with Clopidogrel

Pharmacotherapy, 2009-12, Vol.29 (12), p.1441-1451

2009

Volltextzugriff (PDF)

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

Pharmacotherapy, 2014-10, Vol.34 (10), p.1077-1090

2014

Volltextzugriff (PDF)

Mitochondria‐targeted esculetin inhibits PAI‐1 levels by modulating STAT3 activation and miR‐19b via SIRT3: Role in acute coronary artery syndrome

Journal of cellular physiology, 2018-01, Vol.233 (1), p.214-225

2018

Volltextzugriff (PDF)

PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor

Pharmacotherapy, 2022-12, Vol.42 (12), p.872-879

2022

Volltextzugriff (PDF)

Pharmacogenetics of P2Y 12 receptor inhibitors

Pharmacotherapy, 2023-02, Vol.43 (2), p.158-175

2023

Volltextzugriff (PDF)

Adaptive increase in sample size when interim results are promising: A practical guide with examples

Statistics in medicine, 2011-12, Vol.30 (28), p.3267-3284

2011

Volltextzugriff (PDF)

Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease

Pharmacotherapy, 2017-10, Vol.37 (10), p.1322-1327

2017

Volltextzugriff (PDF)

Key Articles and Guidelines in the Management of Acute Coronary Syndrome and in Percutaneous Coronary Intervention: 2012 Update

Pharmacotherapy, 2012-12, Vol.32 (12), p.e348-e386

2012

Volltextzugriff (PDF)

Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis

Pharmacotherapy, 2019-09, Vol.39 (9), p.912-920

2019

Volltextzugriff (PDF)

Weighted win loss approach for analyzing prioritized outcomes

Statistics in medicine, 2017-07, Vol.36 (15), p.2452-2465

2017

Volltextzugriff (PDF)

Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome

Pharmacotherapy, 2017-08, Vol.37 (8), p.877-887

2017

Volltextzugriff (PDF)

Skew-elliptical spatial random effect modeling for areal data with application to mapping health utilization rates

Statistics in medicine, 2013-01, Vol.32 (2), p.290-306

2013

Volltextzugriff (PDF)

Strategies to Reduce Bleeding Risk in Acute Coronary Syndromes and Percutaneous Coronary Intervention: New and Emerging Pharmacotherapeutic Considerations

Pharmacotherapy, 2014-09, Vol.34 (9), p.973-990

2014

Volltextzugriff (PDF)

Personality Makes a Difference: Attachment Orientation Moderates Theory of Planned Behavior Prediction of Cardiac Medication Adherence

Journal of personality, 2017-12, Vol.85 (6), p.867-879

2017

Volltextzugriff (PDF)

New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

Pharmacotherapy, 2011-10, Vol.31 (10), p.975-1016

2011

Volltextzugriff (PDF)

Estimation of a decreasing hazard of patients with acute coronary syndrome

Statistics in medicine, 2013-03, Vol.32 (7), p.1223-1238

2013

Volltextzugriff (PDF)

Statistical considerations when using a composite endpoint for comparing treatment groups

Statistics in medicine, 2013-02, Vol.32 (5), p.719-738

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel

Pharmacotherapy, 2012-04, Vol.32 (4), p.323-332

2012

Volltextzugriff (PDF)

Effect of the Clopidogrel-Proton Pump Inhibitor Drug Interaction on Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome

Pharmacotherapy, 2012-09, Vol.32 (9), p.809-818

2012

Volltextzugriff (PDF)

Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome

Obesity (Silver Spring, Md.), 2013-09, Vol.21 (9), p.1753-1758

2013

Volltextzugriff (PDF)

Acute Coronary Syndrome Antiplatelet Alternatives in Clopidogrel Allergy

Pharmacotherapy, 2014-08, Vol.34 (8), p.e152-e156

2014

Volltextzugriff (PDF)

Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome

Pharmacotherapy, 2012-03, Vol.32 (3), p.244-273

2012

Volltextzugriff (PDF)

Weight-Based Dosing of Enoxaparin in Obese Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: Results from the CRUSADE Initiative

Pharmacotherapy, 2009-06, Vol.29 (6), p.631-638

2009

Volltextzugriff (PDF)

Mapping Geographic Areas of High and Low Drug Adherence in Patients Prescribed Continuing Treatment for Acute Coronary Syndrome After Discharge

Pharmacotherapy, 2011-10, Vol.31 (10), p.927-933

2011

Volltextzugriff (PDF)

Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome

Proteomics (Weinheim), 2009-04, Vol.9 (7), p.1982-1993

2009

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Humans
(54)
Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Acute Coronary Syndromes
(36)
Pharmacology & Pharmacy
(35)
Acute Coronary Syndrome - Drug Therapy
(25)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Platelet Aggregation Inhibitors - Therapeutic Use
(19)
Male
(18)
Acute Coronary Syndrome
(17)
Pharmacology. Drug Treatments
(17)
Clopidogrel
(16)
Cardiology. Vascular System
(15)
Coronary Heart Disease
(15)
Heart
(15)
Middle Aged
(14)
Myocarditis. Cardiomyopathies
(14)
Aged
(13)
Female
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prasugrel: A Critical Comparison with Clopidogrel

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

Mitochondria‐targeted esculetin inhibits PAI‐1 levels by modulating STAT3 activation and miR‐19b via SIRT3: Role in acute coronary artery syndrome

PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor

Pharmacogenetics of P2Y 12 receptor inhibitors

Adaptive increase in sample size when interim results are promising: A practical guide with examples

Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease

Key Articles and Guidelines in the Management of Acute Coronary Syndrome and in Percutaneous Coronary Intervention: 2012 Update

Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis

Weighted win loss approach for analyzing prioritized outcomes

Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome

Skew-elliptical spatial random effect modeling for areal data with application to mapping health utilization rates

Strategies to Reduce Bleeding Risk in Acute Coronary Syndromes and Percutaneous Coronary Intervention: New and Emerging Pharmacotherapeutic Considerations

Personality Makes a Difference: Attachment Orientation Moderates Theory of Planned Behavior Prediction of Cardiac Medication Adherence

New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

Estimation of a decreasing hazard of patients with acute coronary syndrome

Statistical considerations when using a composite endpoint for comparing treatment groups

Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel

Effect of the Clopidogrel-Proton Pump Inhibitor Drug Interaction on Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome

Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome

Acute Coronary Syndrome Antiplatelet Alternatives in Clopidogrel Allergy

Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome

Weight-Based Dosing of Enoxaparin in Obese Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: Results from the CRUSADE Initiative

Mapping Geographic Areas of High and Low Drug Adherence in Patients Prescribed Continuing Treatment for Acute Coronary Syndrome After Discharge

Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome

Aktive Filter

Suchergebnisse filtern